SF News Global Supplement News Engine
Business

AI Integration Streamlines Ingredient R&D, Compressing Formulation Timelines

Advanced AI adoption by ingredient suppliers, including IFF and Corbion, is accelerating R&D, formulation, and sustainability efforts, promising faster time-to-market for supplement brand owners.

AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →

AI Integration Streamlines Ingredient R&D, Compressing Formulation Timelines

London, United Kingdom — 01 July 2026

Artificial intelligence is transitioning from a nascent tool to a critical infrastructure component within the ingredient innovation sector. Leading suppliers such as International Flavors & Fragrances (IFF) and Corbion are leveraging AI to refine R&D, optimise formulation, and enhance supply chain planning, signalling a significant shift from traditional trial-and-error methodologies. This integration is designed to compress development timelines and improve predictive accuracy, directly benefiting supplement manufacturers by enabling quicker responses to market demands and consumer trends.

Corbion, for instance, employs AI to analyse extensive datasets pertaining to fermentation-based ingredient performance across diverse formulations and processing conditions. Symone Kok, Project Management Director at Corbion, notes that this approach identifies optimisation opportunities far more rapidly than conventional testing. The technology allows simultaneous modelling of multiple variables, accelerating understanding of ingredient behaviour and performance in complex food matrices, effectively augmenting scientific expertise rather than replacing it. This capability translates into more efficient ingredient selection and faster lead times for custom formulations.

Similarly, IFF is embedding AI across its R&D strategy to connect foresight, science, and formulation from initial research stages. Benjamin Mattei, VP Intelligence & Digital Transformation, Taste, explains that AI supports insight development, concept creation, testing, validation, and supply. Tools like IFF’s Concept Muse, an AI-powered engine leveraging proprietary insights, aim to deliver 'first time right' innovation. This capability helps brand owners navigate volatile costs, evolving dietary needs, and fragmented consumer expectations by providing rapid, data-driven formulation adjustments.

AI is also refining consumer insight translation into product outcomes. IFF's intelligence function uses AI to detect patterns and weak signals in online consumer trends and market activity, converting them into actionable insights for formulation. This allows ingredient suppliers to link preference data more directly to formulation decisions, assessing pathways against cost, regulatory, and allergen constraints with greater precision. Corbion combines market-facing and customer-facing data streams to anticipate formulation or food safety challenges, adopting a proactive role in supporting manufacturers.

Furthermore, AI significantly strengthens sustainability initiatives. By modelling outcomes pre-physical trial, AI reduces waste in R&D. Corbion applies predictive modelling for Listeria risk management, simulating microbial outgrowth scenarios to allow proactive formulation adjustments, thereby reducing food waste and potentially costly recalls. IFF uses AI to centralise sustainability data, predicting carbon footprint impact during flavour formulation, driving efficiency and sustainable manufacturing practices.

What this means for United Kingdom

UK supplement manufacturers and brand owners must recognise AI-driven ingredient innovation as a critical competitive differentiator. Expect reduced reformulation windows and faster ingredient sourcing as suppliers utilise AI for increased efficiency. Procurement teams should engage with ingredient partners on their AI capabilities, inquiring about data-driven customisation and accelerated validation processes, which could shorten new product development by 20-25%. Regulatory teams will benefit from AI's enhanced predictive modelling for compliance, particularly for novel ingredients requiring extended shelf-life or safety data. Brands failing to leverage these efficiencies risk longer lead times, higher R&D costs, and slower market penetration against more agile competitors. Prioritise suppliers demonstrating clear AI integration to secure optimal commercial terms and market responsiveness.

Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.